跳至主要内容
临床试验/ISRCTN79220656
ISRCTN79220656暂停未知

High or low dose Syntocinon for induction of labour in nulliparous women: a double blind, randomised controlled trial

Birmingham Women’s and Children’s NHS Foundation Trust0 个研究点目标入组 2,400 人开始时间: 2021年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
暂停
发起方
入组人数
2,400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Nulliparous women at >24 +0/40 weeks gestation
  • 2. Singleton cephalic pregnancy
  • 3. Ruptured membranes undergoing induction of labour
  • 4. Prescribed oxytocin is indicated as part of the induction process
  • 5. Recieved prostin >6 h ago, or propess >30 min ago (if applicable)
  • 6. Clinicians are willing to randomise
  • 7. Give written informed consent to participate prior to randomisation
  • 8. Aged =16 years
  • 9. COVID-19 positive participants are eligible for study inclusion in accordance with local Trust/Health Board policy

排除标准

  • Nulliparous women who:
  • 1. Are in the second stage of labour
  • 2. Have any of the following conditions:
  • 2.1. Existing cardiac disease
  • 2.2. Bleeding disorders
  • 2.3. Previous uterine surgery
  • 2.4. Significant antepartum haemorrhage
  • 3. Have a known contra-indication to oxytocin therapy
  • 4. Are participating in other interventional trials of an Investigational Medicinal Product (IMP) or procedure for induction of labour

研究者

发起方
Birmingham Women’s and Children’s NHS Foundation Trust

相似试验